EvexiTHROID
NDC 73352-696, LEVOTHYROXINE and LIOTHYRONINE, tablet, from Trifluent Pharma, LLC.
- Product NDC
- 73352-696
- Status
- Listed
- Labeler
- Trifluent Pharma, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73352-696 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOTHYROXINE38 ug/1
- LIOTHYRONINE9 ug/1
Pharmacologic classes
Thyroxine [CS]; Triiodothyronine [CS]; l-Thyroxine [EPC]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73352-696-10 | 73352069610 | 100 TABLET in 1 BOTTLE (73352-696-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/40fa228f-9bfc-fc71-e063-6394a90a9ab6NADAC price for package 73352069610
GET /v1/drugs/nadac/73352069610
Use it
Look up 73352-696 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73352-696 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73352-696. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.